A Natural History Study of Patients with Osteogenesis Imperfecta in Italy - Studio di storia naturale in pazienti con osteogenesi imperfetta in Italia

Title

Code

Saturn

Type

Osservazionale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366062

marina.mordenti@ior.it

Mordenti Marina, MSc, PhD

Researcher

Rare skeletal disorders

Operational unit that carry out the study

complex unit

Malattie rare scheletriche

Director

Sangiorgi Luca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. Saturn

Tuesday 5 September 2023, 11:48

PG0012745_2023_Stampa_unica.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

A Natural History Study of Patients with Osteogenesis Imperfecta in Italy - Studio di storia naturale in pazienti con osteogenesi imperfetta in Italia

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

A Natural History Study of Patients with Osteogenesis Imperfecta in Italy - Studio di storia naturale in pazienti con osteogenesi imperfetta in Italia

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in